-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca's third-quarter revenue rose 7% due to growth in the oncology business.

智通財經·10/30/2026 07:17:25
語音播報
AstraZeneca's third-quarter revenue rose 7% due to growth in the oncology business.